logo-loader
CSE:HSM

Helius Medical Technologies

Receive alerts
Market:
CSE
Price
-
Day Change
-
Market Cap:
-
52 weeks high
-
52 weeks low
-

In brief

Helius Medical Technologies Inc., through its wholly-owned subsidiary NeuroHabilitation Corporation, is dedicated to developing products that treat neurological symptoms caused by disease or trauma. The Company's Portable Neuro-modulation Stimulator ("PoNS") device that shows anecdotal promise is making it through the clinical trial process for the treatment of balance disorder in patients who suffered a traumatic brain injury ("TBI") or from neurological disease.